Denosumab
Definition: Denosumab, sold under the brand name Prolia among others, is a human monoclonal antibody used for the treatment of osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone. The most common side effects are joint and muscle pain in the arms or legs. Denosumab is an inhibitor of RANKL (receptor activator of nuclear factor kappa-Β ligand), which works by decreasing the development of osteoclasts, which are cells that break down bone. source: Wikipedia
- ID
- 446321003
- ID date
- 14 Apr 2011
- Previous ID
- 16750211000001101
- Name
- Denosumab